ArticleDrugs in context2024

A prospective, observational, multicentre study to evaluate the efficacy of brivaracetam as adjuvant therapy for epilepsy: The Bravo study.

Fowzia Siddiqui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.